Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2157207 | Radiotherapy and Oncology | 2016 | 5 Pages |
Abstract
Gastric cancer patients have an increased risk of exocrine pancreatic insufficiency after chemoradiotherapy. Thus, the pancreas should be regarded as an OAR. Measuring lipase activity should be the standard for assessing radiation-induced pancreatic injury.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jerzy Wydmanski, Pawel Polanowski, Andrzej Tukiendorf, Barbara Maslyk,